Delivery Order SPE2DB20D3103-SPE2DB25FP0B8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $8,590.58 and an ultimate completion date of August 8, 2025. The contract was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in a quantity of 60 units, with a ceiling value of $8,630.28. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in a 60-count unit, with a contract ceiling value of $17,260.58. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 24, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for the supply of OFEV (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,181.16 to AmerisourceBergen Drug Corp for Ofev 150 mg capsules (60-count units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract carries an ultimate completion date of August 27, 2025, and performance will be executed from the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. The contract is valued at $8,590.58 and represents a firm fixed price delivery order with an ultimate completion date of September 16, 2025. This award is non-set-aside and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 2, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $8,590.58 and an ultimate completion date of June 24, 2025. The contract represents a non-competitive, non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $68,724.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by October 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP0B8Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units, with a ceiling value of $8,590.58. This competitively awarded, non-set-aside delivery order employs firm fixed price terms and is scheduled for ultimate completion on June 23, 2025, following the award date of May 30, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard through this expansive contract vehicle. The DLA Troop Support Medical contract enables the company to fulfill diverse pharmaceutical supply requirements across therapeutic domains to support military healthcare programs globally, demonstrating the company's established capability to meet federal medical procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 5/30/25 |